What to Tell Your Patients When They Want the Truth About Regenerative Medicine for the Spine!-Session Recording

Video Transcription

Video Summary

The session at the conference focused on regenerative medicine for spine conditions, led by Jim Acheson as the moderator. The discussion addressed the need for clarity and evidence-based explanations about regenerative treatments, such as stem cells and PRP (platelet-rich plasma), to better inform patients who are often misguided by sensationalized claims. Presenters like Dr. Jay Bowen, Dr. Mary Ambach, and Dr. Wen-Chun Hsu shared insights from their research and clinical practice. Dr. Bowen emphasized the need for precise data collection and shared the background of prolotherapy and ozone therapy, highlighting their historical and evolving roles in spine care. Dr. Ambach discussed the promising outcomes of PRP for spine conditions, supported by robust studies demonstrating pain and functional improvements, although noting the need for more high-quality data. Dr. Hsu introduced gene and cell therapy, illustrating how cell and gene modifications could further enhance treatment efficacies and highlighting ongoing and future research in this area. They collectively addressed the challenges associated with standardizing methodologies in treatments due to the multifaceted nature of spine conditions and underscored the necessity for comprehensive, data-driven approaches. The presentation concluded with a Q&A where issues around safety, cost, and insurance handling of these novel therapies were discussed, as well as managing patient expectations concerning treatment efficacy and possible side effects. The session called for continued research and regulatory understanding to improve therapeutic strategies and patient outcomes in regenerative spine medicine.

Keywords

regenerative medicine

spine conditions

stem cells

PRP

Jim Acheson

Dr. Jay Bowen

prolotherapy

ozone therapy

gene therapy

cell therapy

patient outcomes